Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant Listeria vaccine strains and methods of using the same in cancer immunotherapy

Recombinant Listeria vaccine strains and methods of using the same in cancer immunotherapy

US Patent 10010593 · Granted Jul 3, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods comprising KLK3 or FOLH1 antigen2022
Compositions comprising angiogenic factors and methods of use thereof2020
Methods for constructing antibiotic resistance free vaccines2019
Non-hemolytic LLO fusion proteins and methods of utilizing same2019
Compositions and methods for treatment of non-hodgkins lymphoma2019
Listeria-based adjuvants2018
Combination immuno therapy and radiotherapy for the treatment of Her-2-positive 2018
Compositions comprising angiogenic factors and methods of use thereof2018
Use of Listeria vaccine vectors to reverse vaccine unresponsiveness in parasitic2018
Compositions comprising angiogenic factors and methods of use thereof2018
Methods for constructing antibiotic resistance free vaccines2017
Compositions and methods comprising KLK3 or FOLH1 antigen2017